Dose Reduction of Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients With Complete Biochemical Response: An Open‐Label Randomized Clinical Trial
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
DOI: 10.1111/jgh.70661
Language: English
Topic: Liver Diseases and Immunity
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7203680896